The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Published Online: 2017-01-18
Journal: Scientific Reports•Publisher: Springer Science and Business Media LLC
Authors: Ana M. B. de Filippis•Andressa Marttorelli•André C. Ferreira•Carolina Q. Sacramento•Caroline S. de Freitas•Diogo A. Tschoeke•Eduardo de Mello Volotão•Erick Correia Loiola•Estevão Portela Nunes•Fabiano L. Thompson•Fernando A. Bozza•Gabrielle R. de Melo•Giselle Barbosa-Lima•Juliana L. Abrantes•Karin Brüning•Lucas Villas Bôas Hoelz•Luciana Leomil•Milene Miranda•Mônica M. Bastos•Natalia Fintelman-Rodrigues•Natasha Rocha•Nubia Boechat•Pablo Trindade•Patrícia T. Bozza•Stevens K. Rehen•Thiago Moreno L. Souza•Yasmine Rangel Vieira
